Vitamin D supplementation and mortality in patients with end-stage renal disease

被引：0
|
作者：
Dierkes, J. [1 ]
Kropf, S. [2 ]
Machlitt, P. [3 ]
Domroese, U. [4 ]
Neumann, K. [4 ]
Westphal, S. [5 ]
Luley, C. [5 ]
Heinz, J. [5 ]
机构：
[1] Univ Bergen, Inst Med, Nutr Unit, N-5020 Bergen, Norway
[2] Univ Magdeburg, Fac Med, Inst Biometry & Med Informat, D-39106 Magdeburg, Germany
[3] Univ Halle, Inst Agr & Nutr Sci, Halle, Germany
[4] Univ Magdeburg, Fac Med, Div Internal Med, D-39106 Magdeburg, Germany
[5] Univ Magdeburg, Fac Med, Inst Clin Chem, D-39106 Magdeburg, Germany
来源：
ANNALS OF NUTRITION AND METABOLISM | 2011年 / 58卷
关键词：
vitamin D end-stage renal disease mortality;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [31] Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data
    Vervloet, Marc G.
    Twisk, Jos W. R.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) : 703 - 706
  • [32] Hemoglobin variability and mortality in end-stage renal disease
    不详
    Nature Clinical Practice Nephrology, 2008, 4 (3): : 122 - 123
  • [33] Mortality and treatment modality of end-stage renal disease
    Schulman, G
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (03) : 229 - 231
  • [34] Is ghrelin a biomarker for mortality in end-stage renal disease?
    Mak, Robert H.
    Cheung, Wai W.
    KIDNEY INTERNATIONAL, 2011, 79 (07) : 697 - 699
  • [35] Hypocalcemia, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Hu, LQ
    ODea, R
    Murray, DC
    Barre, PE
    AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (05) : 386 - 393
  • [36] Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis, Stefanos
    Roumeliotis, Athanasios
    Dounousi, Evangelia
    Eleftheriadis, Theodoros
    Liakopoulos, Vassilios
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (01) : 77 - 90
  • [37] Levels of vitamin D receptor and CYP24A1 in patients with end-stage renal disease
    Ye, Jia-Jun
    Zhou, Tian-Biao
    Zhang, Yun-Fang
    Wang, Qi
    Su, Yan-Yan
    Tang, Jia-Min
    Li, Hong-Yan
    AFRICAN HEALTH SCIENCES, 2016, 16 (02) : 462 - 467
  • [38] Vitamin D deficiency is implicated in reduced serum albumin concentrations in patients with end-stage renal disease
    Yonemura, K
    Fujimoto, T
    Fujigaki, Y
    Hishida, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (02) : 337 - 344
  • [39] Renal ablation in patients with end-stage renal disease
    Hansch, A.
    Pfeil, A.
    Neumann, R.
    Neumann, S.
    Mayer, T. E.
    Wolf, G.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2011, 40 (04) : 308 - 314
  • [40] SLEEP APNEA IN END-STAGE RENAL DISEASE PATIENTS: RISK FACTORS AND MORTALITY
    Prabu, P.
    Waller, J.
    Linder, D.
    Bollag, W.
    Mohammed, A. A.
    Nahman, S.
    Kheda, M.
    Baer, S. L.
    Padala, S.
    Taskar, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 666 - 666
12345